Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Leucemia mielóide aguda-M0 com t(4;11) (q21;q23) após tratamento para sarcoma de Ewing com o protocolo EW92

Autor: Salles,Terezinha J. Marques, Costa,Márcia B., Morais,Vera L. L., J. Filho,Romualdo, Magalhães,Mario H., Silva,Maria L. M., Silva,Sandra M. A., Oliveira,Maria S. Pombo de

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Volume: 26, Issue: 2, Pages: 122-125, Published: 2004
Revista Brasileira de Hematologia e Hemoterapia v.26 n.2 2004
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC

We report on a 7-year-old girl with Ewing's Sarcoma (ES) who developed a poorly differentiated acute myeloid leukemia (AML-M0) 20 months after beginning the EW92 protocol for the treatment of the primary tumor. She received a total dose of 1500 mg of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8661b54f6591f43f35aabb37c5ac6c40
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000200010&lng=en&tlng=en